The TAG-NCD-R&I will provide technical advice to WHO on matters relating to WHO’s work on research and innovation in relation to the prevention and control of NCDs. These include:
Functions
In its capacity as an advisory body to WHO, the TAG-NCD-R&I has the following functions related to research and innovation in relation to the prevention and control of NCDs:
Following a call for interest, WHO initially appointed 12 members of the TAG-NCD-R&I, serving in their personal capacities to represent the broad range of disciplines relevant to research and innovation including but not limited to expertise on the
prevention and control of NCDs. In the selection of the TAG members, consideration was given to attaining an adequate distribution of technical expertise, geographical representation and gender balance. Recognizing the importance of including people
living with NCDs in strategic decision-making processes, WHO also considered lived experience of NCDs in the selection of TAG-NCD-R&I members.
Members of the TAG-NCD-R&I were re-appointed in July 2023 to serve for a further 2 years and shall not be eligible for reappointment beyond 2025 (i.e. the fourth high-level Meeting of the United Nations General Assembly on the Prevention and Control of NCDs).
Their appointment may be terminated at any time by WHO if WHO's interest so requires or, as otherwise specified in these terms of reference or letters of appointment. Where a member’s appointment is terminated, WHO may decide to appoint a replacement member.
TAG-NCD-R&I members must respect the impartiality and independence required of WHO. In performing their work, members may not seek or accept instructions from any government or from any authority external to the Organization. They must be free of
any real, potential or apparent conflicts of interest.
To this end, the members have completed a declaration of interests form and their appointment has been subject to the evaluation of completed forms by the WHO Secretariat, determining that their participation will not give rise to a real, potential or
apparent conflict of interest.
Notwithstanding the requirement to complete the WHO declaration of interest form, TAG-NCD-R&I members have an ongoing obligation to inform the WHO of any interests real or perceived that may give raise to a real, potential or apparent conflict of interest. WHO may, from time to time, request TAG-NCD-R&I members to complete a new declaration of interest form. This may be before a TAG-NCD-R&I meeting or any other TAG-NCD-R&I-related activity or engagement, as decided by WHO. Where WHO has made such a request, the TAG-NCD-R&I member’s participation in the TAG-NCD-R&I activity or engagement is subject to a determination that their participation would not give rise to a real, potential or apparent conflict of interest.
The WHO Technical Advisory Group on NCD-related Research and Innovation (TAG-NCD R&I) was established in July 2021, consisting of 12 experts from...
The WHO Technical Advisory Group on NCD-related Research and Innovation (TAG-NCD R&I) was established in July 2021, consisting of 12 experts from...
The WHO Technical Advisory Group on NCD-related Research and Innovation (TAG-NCD R&I) was established in July 2021, consisting of 12 experts from...
The WHO Technical Advisory Group on NCD-related Research and Innovation (TAG-NCD R&I) was established in July 2021, consisting of twelve experts...
Oman
Neuseeland
United States of America
Indien
Finnland
China
Indonesien
Peru
Nigeria
Vereinigtes Königreich
United States of America